Skip to main content

Table 2 Comparison of parameteric parameters of the three antiviral groups (p > 0.0)

From: Impact of different anti-HCV regimens on platelet count during treatment in Egyptian patients

  Group  
SIM/SOF SOF/RBV Triple p value
Age (years) 55.05 ± 8.00 53.93 ± 9.27 53.55 ± 7.56 0.764
Weight (Kg) 81.73 ± 15.29 81.35 ± 12.41 80.05 ± 13.55 0.626
Height (m) 1.64 ± .08 1.66 ± .10 1.68 ± .09 0.092
BMI (Kg/m2) 30.36 ± 6.09 29.81 ± 4.39 28.40 ± 4.48 0.099
HCV positivity (years) 2.26 ± 2.81 6.67 ± 6.30 * 4.18 ± 5.85 < 0.001
Fib 4 calculation 5.10 ± 2.78 7.77 ± 3.79 * 3.74 ± 1.43 *# < 0.001
Baseline platelets (*1000/mm3) 111.84 ± 40.35 77.18 ± 18.01 * 136.89 ± 31.70 *# < 0.001
Baseline TLC (*1000/mm3) 4.89 ± 1.35 4.89 ± 1.52 5.97 ± 1.99 *# 0.002
Baseline ANC (*1000/mm3) 2.64 ± .95 2.59 ± 1.01 3.11 ± 1.27 *# 0.028
Baseline Hb (g/dl) 12.63 ± 1.38 12.97 ± 1.69 13.86 ± 1.58 *# < 0.001
Baseline Alt (IU/l) 57.35 ± 39.05 64.52 ± 37.95 75.04 ± 58.82 0.198
Baseline Ast (IU/l) 65.58 ± 36.44 78.14 ±
42.81
72.91 ± 51.74 0.106
Baseline Bil T (mg/dl) .99 ± .39 1.18 ± .57 .99 ± .69 # 0.024
Baseline Alb (g/dl) 3.50 ± .46 3.44 ± .46 3.95 ± .44 *# < 0.001
Baseline PC (%) 79.38 ± 12.46 75.20 ± 13.93 81.98 ± 15.38 # 0.015
Baseline Creat (mg/dl) .74 ± .20 .80 ± .19 .83 ± .23 0.088
Creat clearance (ml/min) 120.94 ± 33.11 116.76 ± 31.33 113.68 ± 30.77 0.663
Baseline HCV RNA by PCR (IU/ml) 949,173.30 ± 1195,220.29 1,051,988.49 ± 1,824,411.25 2,473,014.05 ± 6631,407.20 0.256
TSH (μIU/ml) 1.92 ± 1.46 1.97 ± 2.05 1.67 ± 1.20 0.518
Alpha fetoprotien (IU/l) 15.66 ± 22.75 28.92 ± 29.11 * 21.00 ± 30.15 0.001